Pharma News

Study revealed Interactions Between Stress and Self-Control in Human Brain

  • Posted on: 12 August 2015
  • By: Shalini.Sharma

A new study has revealed that even moderate levels of stress can impair self-control. The scientists found that when individuals chose between different food options after having experienced the stressful ice bath treatment, they were more likely to choose an unhealthy food. The study published in the journal Neuron.

Hetero introduce Maball for NHL, CLL patients in India

  • Posted on: 12 August 2015
  • By: Shalini.Sharma

Hetero Group, one of India’s leading generic pharmaceutical companies  has recently announced the launch of its biosimilar ‘Rituximab’ under the brand name Maball in India. It will be marketed and distributed by Hetero Healthcare Limited, a group company of Hetero. Rituximab is recommended as the first-line treatment for NHL and is available in a single dose vial with two strengths – 100mg/10ml and 500mg/50ml.

Ajanta Pharma receives US FDA final approval for generic Singulair tablets

  • Posted on: 11 August 2015
  • By: Shalini.Sharma

Ajanta Pharma Limited, a Rs.1,450 crore plus Mumbai based specialty focused pharmaceutical formulation company, has received final approval from the United States Food and Drug Administration (FDA)  for its 3 Abbreviated New Drug Applications (ANDAs), montelukast tablets, 10mg,  montelukast sodium chewable tablets, 4mg & 5mg and montelukast oral granules.

Pharma Major Lupin starts Research centre in US

  • Posted on: 10 August 2015
  • By: PharmaTutor News

Pharma Major Lupin Limited (Lupin) today announced the opening of its new Center of Excellence for Inhalation Research in Coral Springs, Florida. Local and state leaders, including Florida Lieutenant Governor Carlos Lopez-Cantera, Florida Department of Economic Opportunity Director Jesse Panuccio, and Mayor Skip Campbell, were on site to celebrate the opening of Lupin’s new facility with a ribbon cutting ceremony.

Chiltern announces agreement to acquire Theorem Clinical Research

  • Posted on: 10 August 2015
  • By: PharmaTutor News

Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading global CRO.

Pages